September 25, 2024 Off Cycle Releaseā
User Interface and Data Exchange Users
COVID Vaccines for the 2024-2025 Season
Added new COVID Seasonal NDCs. CAIR users will be able to add new COVID Seasonal vaccines to CAIR Inventory and record administered doses to patientsā records.
Pfizer Comirnaty 12Y+ |
00069-2432-10 |
0069-2432-10 |
10 SYRINGE, GLASS in 1 CARTON |
309 |
91320 |
PFR |
Pfizer Comirnaty 12Y+ |
00069-2432-01 |
0069-2432-01 |
.418 mL in 1 SYRINGE, GLASS |
309 |
91320 |
PFR |
Pfizer BioNTech (Blue Cap) 5Y-11Y |
59267-4438-02 |
59267-4438-2 |
10 VIAL, SINGLE-DOSE in 1 CARTON |
310 |
91319 |
PFR |
Pfizer BioNTech (Blue Cap) 5Y-11Y |
59267-4438-01 |
59267-4438-1 |
.48 mL in 1 VIAL, SINGLE-DOSE |
310 |
91319 |
PFR |
Pfizer BioNTech 6M-4Y |
59267-4426-02 |
59267-4426-2 |
10 VIAL, MULTI-DOSE in 1 CARTON |
308 |
91318 |
PFR |
Pfizer BioNTech 6M-4Y |
59267-4426-01 |
59267-4426-1 |
1.58 mL in 1 VIAL, MULTI-DOSE |
308 |
91318 |
PFR |
Spikevax Moderna COV2 12+ |
80777-0110-96 |
80777-110-96 |
10 SYRINGE, PLASTIC in 1 CARTON |
312 |
91322 |
MOD |
Spikevax Moderna COV2 12+ |
80777-0110-01 |
80777-110-01 |
.5 mL in 1 SYRINGE, PLASTIC |
312 |
91322 |
MOD |
Spikevax Moderna COV2 12+ |
80777-0110-93 |
80777-110-93 |
10 SYRINGE, PLASTIC in 1 CARTON |
312 |
91322 |
MOD |
Moderna COV2 6M-11Y |
80777-0291-80 |
80777-291-80 |
10 SYRINGE, PLASTIC in 1 CARTON |
311 |
91321 |
MOD |
Moderna COV2 6M-11Y |
80777-0291-09 |
80777-291-09 |
.25 mL in 1 SYRINGE, PLASTIC |
311 |
91321 |
MOD |
Moderna COV2 6M-11Y |
80777-0291-81 |
80777-291-81 |
10 SYRINGE, PLASTIC in 1 CARTON |
311 |
91321 |
MOD |
Novavax COV2 12+ |
80631-0107-10 |
80631-107-10 |
10 SYRINGE, GLASS in 1 CARTON |
313 |
91304 |
NVX |
Novavax COV2 12+ |
80631-0107-01 |
80631-107-01 |
.5 mL in 1 SYRINGE, GLASS |
313 |
91304 |
NVX |
Added End Dates to COVID NDCs.
For User Interface, any vaccines from inventory with the following NDCs will display as āNot Validā and the Explanation of Status will indicate āDose was given after NDC end dateā when immunizations are recorded after End Date.
For Data Exchange, when users select the NDCs listed below, immunizations recorded after the End Date will display as āNot Validā and the Explanation of Status will indicate āDose was given after NDC end date.ā
Pfizer Comirnaty 12Y+ |
00069-2377-10 |
8/21/2024 |
Pfizer Comirnaty 12Y+ |
00069-2377-01 |
8/21/2024 |
Pfizer Comirnaty 12Y+āā
|
00069-2362-10 |
8/21/2024 |
Pfizer Comirnaty 12Y+ |
00069-2362-01 |
8/21/2024 |
Pfizer BioNTech (Blue Cap) 5Y-11Y |
59267-4331-02 |
8/31/2024 |
Pfizer BioNTech (Blue Cap) 5Y-11Y |
59267-4331-01 |
8/31/2024 |
Moderna COV2 6M-11Y |
80777-0287-92 |
8/21/2024 |
Moderna COV2 6M-11Y |
80777-0287-07 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-95 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-04 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-96 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-01 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-93 |
8/21/2024 |
Spikevax Moderna COV2 12+ |
80777-0102-01 |
8/21/2024 |
FluMist Trivalent
Added FluMist Trivalent NDCs. CAIR users will be able to add FluMist Trivalent to CAIR Inventory and record administered doses to patientsā records.
FluMist Trivalent |
66019-0311-10 |
66019-311-10 |
10 APPLICATOR in 1 PACKAGE |
111 |
90660 |
MED |
FluMist Trivalent |
66019-0311-00 |
66019-311-00 |
.2 mL in 1 APPLICATOR |
111 |
90660 |
MED |
Added End Dates to FluMist Quadrivalent NDCs.
For User Interface, any vaccines from inventory with the following NDCs will display as āNot Validā and the Explanation of Status will indicate āDose was given after NDC end dateāā when immunizations are recorded after End Date.
For Data Exchange, when users select the NDCs listed below, immunizations recorded after the End Date will display as āNot Validā and the Explanation of Status will indicate āDose was given after NDC end date.ā
FluMist Quaāādrivalent
|
66019-0310-10 |
8/5/2024 |
FluMist Quadrivalent |
66019-0310-01 |
8/5/2024
|
September 18, 2024 (Release 2.8.18)
User Interface and Data Exchange Users
Trivalent Flu Vaccines for 2024-2025 Season1.1 Updated Vaccine names and added Tradenames for the Influenza Seasonal Group.ā
1.2 Added new Influenza Seasonal NDCs.ā
Fluzone High-Dose Trivalent PF
|
49281-0124-65
|
49281-124-65
|
10 SYRINGE, GLASS in 1 PACKAGE
|
135
|
90662
|
PMC
|
Fluzone High-Dose Trivalent PF
|
49281-0124-88
|
49281-124-88
|
.5 mL in 1 SYRINGE, GLASS
|
135
|
90662
|
PMC
|
Fluarix trivalent PF
|
58160-0884-52
|
58160-884-52
|
10 SYRINGE in 1 CARTON
|
140
|
90656
|
SKB
|
Fluarix trivalent PF
|
58160-0884-41
|
58160-884-41
|
.5 mL in 1 SYRINGE
|
140
|
90656
|
SKB
|
Flulaval trivalent PF
|
19515-0810-52
|
19515-810-52
|
10 SYRINGE in 1 CARTON
|
140
|
90656
|
IDB
|
Flulaval trivalent PF
|
19515-0810-41
|
19515-810-41
|
.5 mL in 1 SYRINGE
|
140
|
90656
|
IDB
|
Fluzone trivalent PF
|
49281-0424-50
|
49281-424-50
|
10 SYRINGE, GLASS in 1 PACKAGE
|
140
|
90656
|
PMC
|
Fluzone trivalent PF
|
49281-0424-88
|
49281-424-88
|
.5 mL in 1 SYRINGE, GLASS
|
140
|
90656
|
PMC
|
Afluria trivalent PF
|
33332-0024-03
|
33332-024-03
|
10 SYRINGE, GLASS in 1 CARTON
|
140
|
90656
|
SEQ
|
Afluria trivalent PF
|
33332-0024-04
|
33332-024-04
|
.5 mL in 1 SYRINGE, GLASS
|
140
|
90656
|
SEQ
|
Afluria trivalent preservative
|
33332-0124-10
|
33332-124-10
|
1 VIAL, MULTI-DOSE in 1 CARTON
|
141
|
90658 90657
|
SEQ
|
Afluria trivalent preservative
|
33332-0124-11
|
33332-124-11
|
5 mL in 1 VIAL, MULTI-DOSE
|
141
|
90658 90657
|
SEQ
|
Fluzone trivalent preservative
|
49281-0641-15
|
49281-641-15
|
10 VIAL, SINGLE-DOSE in 1 PACKAGE
|
141
|
90658 90657
|
PMC
|
Fluzone trivalent preservative
|
49281-0641-78
|
49281-641-78
|
.5 mL in 1 VIAL, SINGLE-DOSE
|
141
|
90658 90657
|
PMC
|
Flucelvax trivalent PF
|
70461-0654-03
|
70461-654-03
|
10 SYRINGE, GLASS in 1 CARTON
|
153
|
90661
|
SEQ
|
Flucelvax trivalent PF
|
70461-0654-04
|
70461-654-04
|
.5 mL in 1 SYRINGE, GLASS
|
153
|
90661
|
SEQ
|
Flublok trivalent PF
|
49281-0724-10
|
49281-724-10
|
10 SYRINGE in 1 CARTON
|
155
|
90673
|
PMC
|
Flublok trivalent PF
|
49281-0724-88
|
49281-724-88
|
.5 mL in 1 SYRINGE
|
155
|
90673
|
PMC
|
Fluad trivalent PF
|
70461-0024-03
|
70461-024-03
|
10 SYRINGE, GLASS in 1 CARTON
|
168
|
90653
|
SEQ
|
Fluad trivalent PF
|
70461-0024-04
|
70461-024-04
|
.5 mL in 1 SYRINGE, GLASS
|
168
|
90653
|
SEQ
|
ā
1.3 Added End Dates to Trivalent Flu NDCs.
FLUMIST
|
66019-0108-01
|
111
|
6/30/2011
|
Fluzone High Dose
|
49281-0399-88
|
135
|
6/30/2017
|
AFLURIA Pres Free
|
33332-0009-01
|
140
|
6/30/2024*
|
Fluarix Pres-Free
|
58160-0879-41
|
140
|
6/30/2013
|
Fluarix Pres-Free
|
58160-0881-41
|
140
|
6/30/2015
|
Fluarix Pres-Free
|
76420-0471-01
|
140
|
6/30/2024*
|
Fluzone Pres Free
|
58160-0877-46
|
140
|
6/30/2024*
|
AFLURIA
|
33332-0109-10
|
141
|
6/30/2024*
|
FluLaval
|
19515-0887-07
|
141
|
6/30/2024*
|
Fluvirin
|
76420-0470-10
|
141
|
6/30/2024*
|
Fluzone
|
49281-0009-25
|
141
|
6/30/2024*
|
FLUCELVAX
|
70461-0614-01
|
153
|
6/30/2024*
|
FLUCELVAX
|
70461-0614-11
|
153
|
6/30/2024*
|
Flublok
|
42874-0012-01
|
155
|
6/30/2013
|
Flublok
|
42874-0116-01
|
155
|
6/30/2024*ā
|
Quadrivalent Flu Vaccines Update
2.1 Updated the Quadrivalent Flu Vaccine Names.
828
|
Influenza live quadrivalent intranasal
|
149
|
830
|
Influenza split virus quadrivalent PF
|
150
|
836
|
Influenza split virus quadrivalent Preservative
|
158
|
847
|
Influenza MDCK quadrivalent PF
|
171
|
859
|
Influenza recombinant quadrivalent PF
|
185
|
858
|
Influenza MDCK quadrivalent preservative
|
186
|
872
|
Influenza high-dose quadrivalent PF
|
197
|
873
|
Influenza adjuvanted quadrivalent PF
|
205
|
2.2 Added End Dates for Quadrivalent Flu Vaccines for the 2023-2024 Season.
Afluria Quad Pres-Free
|
33332-0323-03
|
33332-323-03
|
150
|
6/30/2024
|
Afluria Quad Pres-Free
|
33332-0323-04
|
33332-323-04
|
150
|
6/30/2024
|
Afluria, quadrivalent
|
33332-0423-10
|
33332-423-10
|
158
|
6/30/2024
|
Afluria, quadrivalent
|
33332-0423-11
|
33332-423-11
|
158
|
6/30/2024
|
FLUAD Quadrivalent
|
70461-0123-03
|
70461-123-03
|
205
|
6/30/2024
|
FLUAD Quadrivalent
|
70461-0123-04
|
70461-123-04
|
205
|
6/30/2024
|
Fluarix Quadrivalent
|
58160-0909-52
|
58160-909-52
|
150
|
6/30/2024
|
Fluarix Quadrivalent
|
58160-0909-41
|
58160-909-41
|
150
|
6/30/2024
|
Flublok Quadrivalent
|
49281-0723-10
|
49281-723-10
|
185
|
6/30/2024
|
Flublok Quadrivalent
|
49281-0723-88
|
49281-723-88
|
185
|
6/30/2024
|
Flucelvax Quadrivalent
|
70461-0323-03
|
70461-323-03
|
171
|
6/30/2024
|
Flucelvax Quadrivalent
|
70461-0323-04
|
70461-323-04
|
171
|
6/30/2024
|
Flucelvax Quadrivalent
|
70461-0200-12
|
70461-200-12
|
171
|
6/30/2024
|
Flucelvax Quadrivalent
|
70461-0320-03
|
70461-0320-3
|
171
|
7/1/2021
|
FLUCELVAX QUAD (MDV)
|
70461-0423-10
|
70461-423-10
|
186
|
6/30/2024
|
FLUCELVAX QUAD (MDV)
|
70461-0423-11
|
70461-423-11
|
186
|
6/30/2024
|
FluLaval Quad PF 0.5mL
|
19515-0814-52
|
19515-814-52
|
150
|
6/30/2024
|
FluLaval Quad PF 0.5mL
|
19515-0814-41
|
19515-814-41
|
150
|
6/30/2024
|
FLUZONE High-Dose Quadrivalent
|
49281-0123-65
|
49281-123-65
|
197
|
6/30/2024
|
FLUZONE High-Dose Quadrivalent
|
49281-0123-88
|
49281-123-88
|
197
|
6/30/2024
|
FLUZONE High-Dose Quadrivalent
|
49281-0122-88
|
49281-122-88
|
197
|
6/30/2023
|
Fluzone Quad PF 0.5mL
|
49281-0423-50
|
49281-423-50
|
150
|
6/30/2024
|
Fluzone Quad PF 0.5mL
|
49281-0423-88
|
49281-423-88
|
150
|
6/30/2024
|
Fluzone Quad MDV
|
49281-0639-15
|
49281-639-15
|
158
|
6/30/2024
|
Fluzone Quad MDV
|
49281-0639-78
|
49281-639-78
|
158
|
6/30/2024
|
Fluzone Quad MDV
|
49281-0639-15
|
49281-639-15
|
158
|
6/30/2024
|
Fluzone Quad MDV
|
49281-0639-78
|
49281-639-78
|
158
|
6/30/2024ā
|
New Code Sets for Hep A, PCV21 and Typhoid.
3.1 Added New Code sets for Abrysvo, CAPVAXIVE, Harvix and Vivotif.
RSV
|
Abrysvo
|
00069-2465-01
|
0069-2465-01
|
1 in 1 CARTON
|
305
|
PFR
|
RSV
|
Abrysvo
|
00069-2465-10
|
0069-2465-10
|
10 in 1 CARTON
|
305
|
PFR
|
RSV
|
Abrysvo
|
00069-2465-19
|
0069-2465-19
|
.5 mL in 1 VIAL
|
305
|
PFR
|
Hep A - Peds
|
Havrix-Peds 2 dose
|
50090-3781-00
|
50090-3781-0
|
10 SYRINGE in 1 CARTON
|
83
|
SKB
|
Hep A - Peds
|
Havrix-Peds 2 dose
|
50090-3781-01
|
50090-3781-1
|
.5 mL in 1 SYRINGE
|
83
|
SKB
|
PCV21
|
CAPVAXIVE
|
00006-4347-01
|
0006-4347-01
|
1 SYRINGE in 1 CARTON
|
152
|
MSD
|
PCV21
|
CAPVAXIVE
|
00006-4347-02
|
0006-4347-02
|
10 SYRINGE in 1 CARTON
|
152
|
MSD
|
PCV21
|
CAPVAXIVE
|
00006-4347-99
|
0006-4347-99
|
.5 mL in 1 SYRINGE
|
152
|
MSD
|
Typhoid - Oral
|
Vivotif/Ty21a
|
50632-0016-02
|
50632-016-02
|
1 BLISTER PACK in 1 CARTON
|
25
|
BN
|
Typhoid - Oral
|
Vivotif/Ty21a
|
50632-0016-04
|
50632-016-04
|
4 CAPSULE, COATED in 1 BLISTER PACK
|
25
|
BN
|
ā
3.2 Added End Dates to Pfizer Comirnaty NDCs.
Pfizer Comirnaty 12Y+
|
00069-2392-01
|
0069-2392-01
|
309
|
6/30/2024
|
Pfizer Comirnaty 12Y+
|
00069-2392-10
|
0069-2392-10
|
309
|
6/30/2024
|
ā
RabAvert Update
4.1 Associated MVX code BN with CVX code 176 (Tradename RabAvert)
Assigned the MVX code of BN to NDC 50632-0010-01.
Assigned the MVX code of BN to NDC 50632-0013-01.
4.2 Added End Date RabAvert NDC.
RabAvert
|
50632-0011-01
|
50632-011-01
|
176
|
03/22/2024ā
|
Historical Entry Update
5.1ā Updated āSource of Immā list for Historical entry.
āSource of Immā list:
- Source Unspecified
- Other Provider
- Parent Written Record
- Parent Recall
- Other Registry
- Birth Certificate
- School Record
- Public Agencyā
August 21, 2024 (Release 2.8.17)
ā1. Bug Fixes /Enhancements
The following fixes appear in this release:ā
Schedule Outlier
1.1. Updated the following series recommendation to list PCV NOS, the PCV vaccine group default vaccine, when the series is complete.
ā
PCV13 Adult
PCV13 PCV15 Child
PCV13 PCV15 Late Start 12M
PCV13 PCV15 Late Start 24M
PCV13 PCV 15 Late Start 7M
PCV15 Adult
PCV20 Adult 1 Dose
1.2. Updated the following series recommendation to list Pneumococcal 23, the vaccine group default vaccine, when the series is complete.
PPSV23 Adult
1.3. Added Booster to Japanese Encephalitis schedule.
1.4. Added Booster to Tick-Borne schedule for Adult.
1.5. Added Booster to Tick-Borne schedule for Child.
2. Added the following options when two vaccines are given within a short window from one another using āFrom CAIR Inventory:ā Update, Add Pending and Cancel.
3. Removed mm values from T-Spot Result screen.
ā
July 24, 2024 (Release 2.8.16)
1. Bug Fixes /Enhancements
The following fixes appear in this release:ā
āData Exāchangeā
- Fixed issue identified where Shot Giver names were not being saved to a dose administered and submitted through Data Exchange. This was due to the presence of special characters in the applicable fields when submitted through Data Exchange. The issue contributed to incomplete data on the patient record and the Dose Administered Report. Special characters will be allowed Via DX as they are through the User Interface.
- Add new Non-US NOS Fractional Inactivated Polio vaccine (fIPV) CVX Code 324 to CAIR. These doses can only be entered as Historical and will not appear in the Trade Name dropdown options.
- āVaccine Group: 20 Polio
- TRADE NAME:
No TRADE NAME
- Vaccine Name: Fractional dose fIPV NOS Non-US
- CVX code: 324
- MVX: UNK
- NDC: no NDC codes. Vaccine is NOS and Non-US code, so should follow Non-US criteria.
- āAdded End Dates to MDC Codes for Cholera vaccine Menactra.
- Inactivate the following NDC codes for Menactra CVX 114 MVX PMC
User Interface
- Removed the mm values in the Panel-A-nil and Panel B-nil dropdown options for TB T-Spot Test results.
- Fixed Reminder Recall Report error when using āUse Vaccine Groups Selected.ā An error was reported when a user would select 12 vaccines groups to run the report.
- Fixed Dose Administered Report to display the 317 Funding under Funding Source and Patient Eligibility columns. After updating CAIR to include the Bridge Funding, these columns displayed blank.ā
June 2, 2024 (Release 2.8.14)
āāā1. Bug Fixes /Enhanācements
The following fixes appear in this release:ā
āData Exāchange
- āAdded New CVX code 318 NDC Codes for CYFENDUSā
-
Trade Name CYFENDUS attached to CVX 24 CPT 90581 and Vaccine ID 3 need to be cross walked to Anthrax CVX 24 CPT 90581 and Vaccine ID 3 if the date of administration is < 9/19/2023.
-
New CVX Code 318 updated to be assigned to Trade Name CYFENDUS, Vaccine Group Anthrax 03, Vaccine Name Anthrax post-exposure prophylaxis, CVX Code 318, and CPT Code 90581āÆ
-
CYFENDUS NDCās are 71665-0001-01āÆ - 5 mL in 1 VIAL, MULTI-DOSE and 71665-0001-02 - 10 VIAL, MULTI-DOSE in 1 CARTON. CVX code updated to 318āÆ
-
All IMMs prior to 9/19/2023 with CYFENDUS as vaccine given updated to be assigned Anthrax CVX 24.
-
Disassociated trade name CYFENDUS from CVX 24 and associate the trade name to CVX 318.
-
For CYFENDUS CVX 24 IMMs with the Date of administration
-
9/19/2023, with NDCs assigned, belonging to CYFENDUS CVX 318 reassign the IMMs to CYFENDUS CVX 318.ā
- āAdd Unspecified Anthrax Vaccine CVX Code 319.
-
āāAll anthrax CVX codes are associated with vaccine group ANTHRAX.
- The following CVX code needs to be added as the NOS for the Anthrax vaccine group.
-
āAdd Anthrax vaccine, unspecified to CAIR2 as specified below.
319 (NEWāā) |
Anthrax vaccine, unspecified |
Anthrax vaccine, unspecified |
Inactive ā
|
-
Note thāat unspecified codes āare added with a status of āInactive.ā
-
NOS (Unspecified codes) have no NDCs assigned and are sent as historical doses.
-
Code to be added to the NOS list for DX processing.
-
This vaccine, CVX 319 is the new default value for the anthrax vaccine group.
Note: Code will not appear on any Trade Name lists and when adding it through the UI user should add it using the Add Historical option and it should be added on the āAdd Historicalā date grid.
User Interface
āāJune 13, 2023 (Release 3.8.3.11)
1. Bug Fixes/Enhancemeānts
The following fixes appear in this release:ā
Data Exāchange
- āUpdate RXA-17 Substance Manufacturer Name (CE) 01131 field to display CE data type where |manufacturer code^manufacturer name^MVX| displays.
- Update RSP for protected clients. RSP returned for patients that do not agree to share, the value returned in QAK-2 was āNF,ā meaning Patient Not Found. The value now returned in QAK-2 of the RSP on a protected record will equal āPDā for Protected Data.
- RSP increment PID-1 when multiple patients are returned. Update the code in the RSP process to increment the PID-1 by 1 each time a new result is created. Multiple results of the client records will be numbered sequentially.
- Added CVX Code 198 Non-US Pentalvalentā
- āUpdate Vaccine id 801 DTP-Hib-HepB to replaced CVX 102 with 198.
- Update all instances of immunizations, and lots with CVX 102 to be 198.ā
-
Add CVX 198 to crosswalk list of non-US vaccines that reject RXA if sent to CAIR as administered vaccine, RXA-9 historical indicator =00.
User Interface
2. āNew Features
No new features added.āā
āāApril 12, 2023 (Release 3.8.3.9)
ā1. Bug Fixes/Enhancements
The following fixes appear in this release: